Cairina Inc., a biomedical company specializing in advanced cancer diagnostics, has been selected for the Regional Acceleration and Mentoring Program (RAMP), which provides high-growth startups with mentorship, business development resources, and investor connections.
Cairina’s software revolutionizes cancer treatment by generating highly detailed, 3D-rendered models that map the fluid dynamics around a cancer patient’s tumor. These precise visualizations help surgeons navigate with greater accuracy in the operating room, optimize radiotherapy and drug delivery, and offer early insights into treatment response and disease progression.
Unlike other solutions, Cairina’s platform integrates seamlessly into existing clinical workflows, requiring no additional imaging or specialized equipment—making advanced, personalized cancer care more accessible.
“RAMP provides the support we need to accelerate commercialization and expand access to this technology,” said Jennifer Munson, president and co-founder of Cairina.
Key Features of Cairina’s Technology:
- 3D Fluid Dynamics Modeling: Provides a clear, patient-specific map of tumor microenvironments.
- Precision Treatment Planning: Enhances surgical accuracy, radiotherapy targeting, and drug delivery.
- Fast, High-Resolution Analysis: Processes datasets in 90 seconds—20x faster than traditional methods.
- Seamless Integration: Works with existing imaging systems without requiring new hardware.
- Early Response Detection: Helps clinicians track treatment effectiveness and disease progression in real time.
Through RAMP, Cairina will refine its business model, strengthen research collaborations, and pursue funding to bring its technology to more clinicians and patients.
For more information, message Cairina at [email protected].
